Summary:
Cheiron is the first pharmacy-specific platform powered by generative AI in South Korea.
Utilizes a modular RAG framework for semantic-based search and data retrieval.
Claims to reduce document search time by up to 80% compared to existing methods.
Supports various workflows including research, clinical trial design, and market analysis.
Aligns with the trend of genAI solutions in the pharmaceutical industry.
An AI startup backed by SK Group has launched what may be the first pharmacy-specific platform powered by generative AI in South Korea. The platform, named Cheiron, is designed for pharmaceutical professionals, including researchers and pharmacists, and is the flagship AI solution from PhynX Lab, a Silicon Valley-based venture under SK Networks.
How It Works
Key features of Cheiron include one-stop and semantic-based search capabilities. Utilizing a modular RAG framework—an advanced version of Retrieval-Augmented Generation—Cheiron retrieves relevant information from various databases to generate responses. It can select specific data based on intent using natural language processing, self-verify information, and quickly generate high-quality answers.
The modular RAG system is praised for its expandability to new technologies or data, allowing for flexible and easy module connections, akin to Lego blocks. Moreover, it optimizes data storage selection, enhancing security.
Cheiron can pull information from multiple academic search platforms like PubMed, general search engines, open sources, and internal corporate documents, all through a single interface. Additionally, it automates workflows, including data organization and document creation, and supports multiple languages beyond Korean.
Why It Matters
PhynX Lab developed Cheiron to overcome the limitations of existing healthcare LLMs. They argue that current models often misinterpret data and provide unfounded answers based on outdated information. In user tests, Cheiron reportedly reduces document search time, potentially speeding up research planning by up to 80% compared to traditional methods. Beyond search, Cheiron facilitates research and substance discovery, clinical trial design, production, and market analysis.
The Larger Trend
This launch aligns with a growing trend in the pharmacy industry to leverage genAI solutions for new drug development. Earlier this year, Daewoong Pharmaceutical revealed its own genAI-powered drug discovery platform, while companies like Google and IBM are also exploring AI applications in pharmaceutical research.
Comments